Urologic Care for the Advanced Practice Provider Webcast (2020): Saturday

LED BY COURSE DIRECTORS, ANNE CALVARESI, DNP, CRNP AND JIM KOVARIK, PA-C, THIS WEBCAST FEATURES INTERACTIVE, CLINICALLY RELEVANT PROGRAMMING DEVELOPED BY APPS FOR APPS! TOPICS INCLUDE:

  • Oncology
  • Technology and Pharmacology
  • Urolithiasis
  • Infections/Inflammations
  • Men’s Health
  • Voiding Dysfunction
  • Best Practices and Practice Integration: An APP Practice Management Panel Discussion

This set of videos features programming presented on the first day of the Urologic Care for the Advanced Practice Provider Webinar. See the program tab for full details. 

Target Audience

  • Physician Assistants
  • Advanced Practice Nurses
  • Registered Nurses
  • Allied Health Care Professionals

 

Learning Objectives

At the conclusion of this activity, participants will be able to:

  1. Define active surveillance and identify appropriate candidates and discuss tools & templates for active surveillance and triggers to discontinue active surveillance. 
  2. Recognize and explain the appropriate treatment and follow-up for patients with superficial bladder cancer. 
  3. Outline an approach to telehealth for APPs. 
  4. Utilize available perioperative risk stratification tools to assess thromboembolic risk and bleeding risk in patients taking antithrombotic medications in order to develop a perioperative antithrombotic management plan for elective surgeries.
  5. Identify and discuss the management of complex nephrolithiasis cases. 
  6. Comprehend and recognize the differential diagnosis and evaluation algorithm for patients with micro and macroscopic hematuria presenting in the office setting.
  7. Discuss what is and is not classified as a complicated UTI and the evaluation and management of those infections.(
  8. Ascertain the concept of shared decision making for the evaluation and treatment of Erectile Dysfunction (ED).
  9. Analyze the latest evidence on the surgical management of lower urinary tract symptoms associated with benign prostatic hyperplasia or BPH/LUTS.
  10. Differentiate between storage or emptying in a neurogenic bladder in order to properly treat and prevent complications. 
  11. Identify mechanisms and risks associated with 3rd line treatment options for overactive bladder. 
  12. Identify common problems associated with neurogenic and overactive bladder.
  13. Discuss optimal utilization of urologic Advanced Practice Providers. 
Course summary
Available credit: 
  • 7.00 AMA PRA Category 1 Credit™
  • 7.00 Non-Physician Participation
Course opens: 
05/29/2020
Course expires: 
06/01/2023
Part of: 
Urologic Care for the Advanced Practice Provider Webcast (2020)
Rating: 
0

Session I: Oncology

  • Welcome/Introduction: Anne Calvaresi, DNP, CRNP; Jim Kovarik, PA-C
  • Prostate Cancer: Active Surveillance Management: Jim Kovarik, PA-C
  • Abstract Presentation: Assessing Quality and Safety of an Advanced Practice Provider led Active Surveillance Clinic for Men with Prostate Cancer – Xin Lin, NP
  • Role of Genetics for Urologic Cancers: Leonard G. Gomella, MD, FACS
  • Diagnosis and Management of Superficial Bladder Cancer: Anne Calvaresi, DNP, CRNP
  • Podium Presentation – Testicular Mass in a Prostate Cancer Survivor: Diagnosis Management – Mary Dunn, MSN, RN, OCN, NP-C
  • Podium Presentation – GU Hereditary Genetic Counseling and Testing: Prostate Kidney and Bladder Cancer, Oh My! – Lindsey Byrne, MS, LGC
  •  AUAUniversity Demo for the NEW APP Curriculum: Mary Dunn, MSN, RN, OCN, NP-C

Session II: Technology & Pharmacology

  • Telehealth in Urology Practice: Stanley Mukundi, PA-C
  • Perioperative Antithrombotic Therapy Management: Sarah Stanley, PA-C
  • Podium Presentation – Advocacy and the Advanced Practice Provider: Why State and Federal Advocacy Should be an Integral Component of Your Professional Life – Adele Caruso, DNP, CRNP
  • Podium Presentation – Decreasing Post-Operative Opioid Use While Simultaneously Managing Pain: A Prospective Study of Men Who Underwent Scrotal Surgery – Libert Ramos, DNP, MSN/Ed, APRN
  • Podium Presentation – Changes & Challenges and Tips & Tricks to Assisting in Single-Port Robotics Cases – Ashleigh Renitsky, PA-C

Session III: Urolithiasis

  • Challenging Urolithiasis Case Panel Discussion
    • Moderator: Anne Calvaresi, DNP, CRNP
    • Panelists: Jim Kovarik, PA-C; Leslie Lorbacher, NP
  • Pediatric Urology 101: Heidi A. Stephany, MD
  • Podium Presentation – Transition Care for the Young Adult with Congenital Urologic Conditions – Rachel Shapiro, PA-C 

METHOD OF PARTICIPATION: 

Learners will participate in this online educational activity by taking the pretest, viewing the webcast and completing the posttest and evaluation. To claim CME credit for this enduring material, learners must complete the posttest, passing with 80% accuracy and submit the program evaluation.

Estimated time to complete this activity: 7.00 hours

Release Date: June, 2020
Expiration Date: June, 2023

ACCREDITATION: 

The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: 

The American Urological Association designates this enduring activity for a maximum of 7.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER LEARNERS: 

The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

EVIDENCE BASED CONTENT: 

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA DISCLOSURE POLICY: 

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

RESOLUTION OF IDENTIFIED CONFLICT OF INTEREST: 

All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES: 

The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Available Credit

  • 7.00 AMA PRA Category 1 Credit™
  • 7.00 Non-Physician Participation
Please login or register to take this course.